• Cite Icon1
  • https://doi.org/10.1002/9781119233053.ch9Copy DOI Icon

Immune‐Mediated Skin Diseases

  • May 6, 2017
  • Ariane Neuber +1 more
Show More
  • Abstract
  • Literature Map
  • Citations
  • Similar Papers
Abstract

Immune-mediated skin diseases, with the exemption of hypersensitivity disorders, are relatively uncommon conditions. The immune system protects the body from external threats by distinguishing self from non-self and attacking foreign antigens. Immunosuppressive treatments are therefore used to decrease the inappropriate immune response. Anti-nuclear antibodies (ANA) are antibodies against epitopes in the nucleus such as histones and single- and double-stranded DNA. Coomb's testing is useful in the diagnosis of immune-mediated haemolytic anaemia (IHA). Rheumatoid factor (RF) is a non-specific autoantibody with an unknown target, which may be found in a number of inflammatory, infectious and neoplastic diseases. Systemic lupus erythematosus (SLE) frequently involves immune-complex glomerulonephritis, which can result in elevated urinary protein levels. Haematology, biochemistry, urinalysis and other tests may be appropriate in multi-systemic disorders. Many treatments for immune-mediated skin diseases can have serious adverse effects and routine blood and urine tests are important for monitoring.

Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.